These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18220940)

  • 1. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
    Schäfer A; Bauersachs J
    Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet in progression of atherosclerosis: a potential target in diabetic patients.
    Koyama H; Nishizawa Y
    Curr Diabetes Rev; 2005 May; 1(2):159-65. PubMed ID: 18220591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
    Flierl U; Bauersachs J; Schäfer A
    Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
    Flierl U; Schäfer A
    Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in atherosclerosis and thrombosis.
    Schulz C; Massberg S
    Handb Exp Pharmacol; 2012; (210):111-33. PubMed ID: 22918729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and platelet-derived microparticles in vascular inflammatory disease.
    Vasina E; Heemskerk JW; Weber C; Koenen RR
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):346-54. PubMed ID: 21054257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
    Willerson JT
    Tex Heart Inst J; 1995; 22(1):13-9. PubMed ID: 7787465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and chemokines in atherosclerosis: partners in crime.
    Weber C
    Circ Res; 2005 Apr; 96(6):612-6. PubMed ID: 15802619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction--assessment of current status and approaches to therapy].
    Simon BC; Noll B; Maisch B
    Herz; 1999 Feb; 24(1):62-71. PubMed ID: 10093015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of platelets in atherosclerosis and inflammation].
    Siegel-Axel D; Langer H; Lindemann S; Gawaz M
    Med Klin (Munich); 2006 Jun; 101(6):467-75. PubMed ID: 16767570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelets, coagulation, and fibrinolysis in atherosclerosis formation].
    Ishii H; Yoshida M
    Nihon Rinsho; 2011 Jan; 69(1):50-4. PubMed ID: 21226260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-leukocyte-endothelial interactions in coronary artery disease.
    Mehta JL; Nicolini FA; Donnelly WH; Nichols WW
    Am J Cardiol; 1992 Mar; 69(7):8B-13B. PubMed ID: 1543143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.